Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Carbocisteine or Hypertonic Saline for Acute Respiratory Failure.

The New England journal of medicine·2026
Same author

TP53 mutation at codon 179 metabolically reprograms cancer cells to promote invasion.

Cancer gene therapy·2026
Same author

YBX1 Expression Marks Proliferative Tumour States with Context-Dependent Genomic Instability: A Pan-Cancer Analysis.

International journal of molecular sciences·2026
Same author

<i>TP53</i> Splice Mutations Have Tumour-Independent Effects on Genomic Stability and Prognosis: An In Silico Study.

International journal of molecular sciences·2025
Same author

Continuous infusion of Beta-Lactams in the critically ill: Considerations for global implementation.

Journal of critical care·2025
Same author

Δ133p53 isoform enhances TLR4 function to promote tumor growth.

Carcinogenesis·2025

Related Experiment Video

Updated: May 25, 2026

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
08:57

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Published on: October 6, 2019

Does Δ133p53 isoform trigger inflammation and autoimmunity?

Hamish G Campbell1, Tania L Slatter, Aaron Jeffs

  • 1Children's Medical Research Institute, University of Sydney, Sydney, NSW, Australia.

Cell Cycle (Georgetown, Tex.)
|January 21, 2012
PubMed
Summary

The tumor suppressor p53 isoform, delta 133 p53 (Δ133p53), drives autoimmune disease development. Mice lacking Δ122p53 exhibit autoimmune symptoms and inflammation, linked to STAT1 pathway activation, a signature also seen in human lupus patients.

More Related Videos

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Related Experiment Videos

Last Updated: May 25, 2026

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
08:57

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Published on: October 6, 2019

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Autoimmune diseases involve the immune system attacking self- tissues, with unclear causes.
  • The tumor suppressor protein p53 has isoforms, including Δ133p53, whose roles in autoimmunity are unexplored.

Purpose of the Study:

  • To investigate the involvement of the p53 isoform Δ133p53 in the development of autoimmune diseases.

Main Methods:

  • Generated a mouse model (Δ122p53) lacking the Δ133p53 isoform.
  • Analyzed autoimmune/inflammation-like phenotypes, including autoantibodies and cytokine levels.
  • Utilized microarray analysis to identify gene expression changes and validated findings in human cells.

Main Results:

  • Δ122p53 mice developed autoantibodies, elevated pro-inflammatory cytokines, and lymphocyte aggregations.
  • Microarray analysis revealed Δ122p53 expression induced pro-inflammatory genes, including the STAT1 pathway and interferon-related profiles.
  • Identified similar genetic signatures in human systemic lupus erythematosus (SLE) patients and demonstrated Δ133p53 regulation of STAT1 in human cells.

Conclusions:

  • p53 isoforms, specifically Δ133p53, play a significant role in the development of autoimmune diseases.
  • The study establishes a novel link between p53 isoforms and autoimmunity, highlighting the STAT1 pathway as a key mediator.
  • Findings suggest potential therapeutic targets for autoimmune conditions by modulating p53 isoform activity.